CELL BASED IMMUNOTHERAPY MARKET SIZE & SHARE ANALYSIS - GROWTH TRENDS & FORECASTS (2023 - 2028)


Cell Based Immunotherapy Market Analysis:

The market for cell-based immunotherapy is expected to exhibit a compound annual growth rate (CAGR) of 15.5% during the forecast period. The COVID-19 pandemic had a significant impact on the market during its initial stages, resulting in delayed elective surgeries, follow-up appointments, and the cancellation or postponement of certain types of cancer treatments as hospitals prioritized care for seriously ill COVID-19 patients. For example, a March 2022 article published in PubMed reported that many patients receiving subcutaneous immunotherapy (SCIT) were forced to discontinue or postpone treatment due to the epidemic.

Interestingly, cell-based immunotherapies were used to treat COVID-19 during the pandemic. According to a June 2022 article published in PubMed, innovative adaptive immune cell treatment provided a viable preventative or therapeutic option for patients with moderate-to-severe COVID-19. This strategy aimed to increase safety, provide effective therapy, and supplement routine therapy for all COVID-19-infected patients. Following the pandemic, the market is expected to grow due to the increasing prevalence of cancer, technological advancements in developing target-based anticancer therapy, and the launch and approval of various cell-based immunotherapies.

For example, according to an American Cancer Society 2022 update, an estimated 1.9 million new cancer cases were reported in the United States in 2022. Additionally, advancements in products, increasing approvals, clinical trials, partnerships, and collaborations by key players are contributing to market growth. In June 2022, Immuneel Therapeutics, a biotech start-up, began patient dosing in a CAR-T trial named IMAGINE. This phase II trial, which is actively enlisting patients in Bengaluru for clinical trial development, is one of the first industry-sponsored CAR-T trials in India. Such clinical trial developments are expected to increase demand for cell-based immunotherapy. Furthermore, an increase in research and development in cell-based cancer therapy is likely to drive market growth over the forecast period. For example, a June 2022 article published in Frontiers reported that most current evaluation-stage strategies take advantage of the safety of T-cell activation and incorporate tumor-targeting mechanisms, such as chimeric antigen receptors (CARs) or bispecific T cell engagers (bsTCEs), which are likely to be essential to achieving more robust and reliable clinical responses.

Therefore, due to several factors, the cell-based immunotherapy market is expected to witness growth over the analysis period. However, the high cost of technology and lack of awareness in developing markets are likely to impede market growth.

Get the free sample report of the Cell Based Immunotherapy Market

Comments

Popular Posts

Aviation Industry Set to Soar: Market to Hit USD 395.76 Billion by 2030 Amid Stable Growth

Recreational Boating Market Set to Reach USD 36.82 Billion by 2030: Key Growth Drivers and Trends

Kuwait Dairy Products Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Coffee Machine Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)